# DePuy Synthes to acquire Gemtrack technology from MinMaxMedical

DePuy Synthes announced a definitive agreement to acquire selective rights to develop, manufacture and commercialize Gemtrack technology from MinMaxMedical for use across its Joints portfolio, including shoulder, hip and knee, for navigation and robotic applications.

- Type: Acquisition
- Announced: 2026-05-26
- Where: United States
- Status: announced
- Products: RF miniature tracker technology for joint reconstruction
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [DePuy Synthes](https://endata.com/companies/21191.md)
- [DePuy Synthes](https://endata.com/companies/21191.md) (acquirer)
- [MinMaxMedical](https://endata.com/companies/32100.md) (target)
- [MiniMaxMedical](https://endata.com/companies/92485.md) (target)

## Sources

- [jnj.com](https://www.jnj.com/media-center/press-releases/depuy-synthes-announces-agreement-to-acquire-miniature-radiofrequency-tracking-technology-across-its-joint-reconstruction-portfolio), 2026-05-26: "This new collaboration will be applied broadly to the VELYS ecosystem to reduce the reliance on line-of-sight dependent navigation and offering the potential for improved navigation precision."
- [g-medtech.com](https://g-medtech.com/news/depuy-synthes-announces-two-strategic-agreements-to-expand-orthopaedic-portfolio/), 2026-05-27: "The company has signed a definitive agreement to acquire selective rights to develop and commercialize Gemtrack technology across its Joints portfolio, including shoulder, hip, and knee procedures."
- [healthindustryhub.com.au](https://www.healthindustryhub.com.au/medical-technology-news-trends/depuy-synthes-strikes-deal-ahead-of-split-from-johnson-johnson/), 2026-06-16: "DePuy has agreed to acquire selective rights to Gemtrack technology, securing the ability to develop, manufacture and commercialise the platform across its joints portfolio."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.